Security key
92941V308
VYNE Therapeutics Inc. - common stock, par value $0.0001 (VYNE)
CUSIP: 92941V308
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / common stock, par value $0.0001
- Total 13F shares
- 35,000
- Total 13F value
- $22,000
- Share change
- 0
- SEC-reported price per share
- $0.63
- Number of holders
- 1
- Shares outstanding
- 33,403,382
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
VYNE full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
VYNE Therapeutics Inc. SEC filings
VYNE Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92941V308
Recent filing periods:
Ownership snapshot
Top reported holders of VYNE - VYNE Therapeutics Inc. - common stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 6%
13D/G row: Nantahala Capital Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Nantahala Capital Management, LLC leads the comparable SEC ownership view at 6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Nantahala Capital Management, LLC
6%
CITADEL ADVISORS LLC
0.01%
Lynx1 Capital Management LP
4.9%
Shay Capital LLC
4.8%
Anson Funds Management LP
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
6%
|
$1,195,000
2,000,000 shares
|
$0 | 31 Mar 2026 |
| CITADEL ADVISORS LLC |
13F
13D/G
Company · Kenneth Griffin
|
0.01%
from 13D/G
|
$307,380
514,443 shares
|
— | 31 Mar 2026 |
| Lynx1 Capital Management LP |
13F
Company
|
4.9%
|
$973,148
1,628,700 shares
|
— | 31 Mar 2026 |
| Shay Capital LLC |
13F
Company
|
4.8%
|
$962,120
1,610,242 shares
|
— | 31 Mar 2026 |
| Anson Funds Management LP |
13F
Company
|
3.7%
|
$742,756
1,243,106 shares
|
— | 31 Mar 2026 |
| ADAR1 Capital Management, LLC |
13F
Company
|
3.2%
|
$635,680
1,063,899 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
35,000
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
42
Q2 2026 holders
1
Holder diff
-41
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend